Interventional/Surgery
16 COMMENTS - May 22, 2013 08:10 EDT
At a meeting famous for showcasing flashy new interventional devices, one session sought to shine a light on a tenacious old problem. It's time for interventionalists to step up and take action, say two leaders in this field.
Clinical cardiology
2 COMMENTS - May 22, 2013 16:30 EDT
Patients who have an MI or develop heart failure in a part of the country with a low density of practicing cardiologists have a slightly higher risk of death at 30 days and one year compared with those who have the same clinical events in an area more densely populated with cardiologists.
Thrombosis
1 COMMENT - May 22, 2013 10:30 EDT
The use of venous thromboembolism prophylaxis does not curb events, new research shows.
Acute Coronary Syndromes
1 COMMENT - May 21, 2013 13:50 EDT
Investigators for a new SCAAR registry analysis point out that bivalirudin has been widely studied only against a combination of GP IIb/IIIa inhibition and heparin, but that heparin alone is cheaper and yielded similar 30-day mortality rates in this patient group.

Editorial series

Debate and dialogue between top cardiovascular specialists, produced by theheart.org's editorial team
Editorial series
May 23, 2013 10:58 EDT
View our slideshow for a top-line summary of news-making presentations at HRS 2013, including NCDR PINNACLE, BRUISE CONTROL, and the long-term PROTECT-AF analysis.
Editorial series
May 2, 2013 08:45 EDT
Join Drs Melissa Walton-Shirley and Timothy Gardner for a calm, in-depth discussion on some of the issues raised by President Obama's healthcare reform, including 30-day readmission rates and penalties.
Editorial series
Apr 12, 2013 16:33 EDT
Drs Timothy Gardner, Cindy Grines, and Sanjay Kaul sit down with heartwire's Shelley Wood to discuss what happened at the ACC, if the punishment fit the crime, and why the release of trial data may need an overhaul.
Editorial series
4 COMMENTS - Mar 19, 2013 10:00 EDT
View our slideshow for a top-line summary of news-making clinical trials, including PREVAIL, CHAMPION-PHOENIX, STREAM, and HPS2-THRIVE at ACC 2013.
Discussion and opinions
A fresh take on current cardiology affairs by theheart.org contributors

Topolog by Dr Eric Topol
Topolog
May 08, 2013 17:00 EDT
The GISSI group's impressive, collaborative study just published in NEJM puts to bed any lingering theory stipulating a positive effect of fish oils to prevent heart disease in patients who have not had an MI and do not have HF.
Most recent posts
theheart.org forum theheart.org forum
Exchanges among healthcare providers, clinicians, and researchers
Visit the forum »
Most popular
Membership is free!
Inside Themes
Acute Coronary Syndromes
Interventional/Surgery
Interventional/Surgery
Arrhythmia/EP
Lipid/Metabolic
Acute Coronary Syndromes
Acute Coronary Syndromes
Acute Coronary Syndromes
Lipid/Metabolic
Interventional/Surgery
Hypertension
Interventional/Surgery
Hypertension
Clinical cardiology
Clinical Cardiology
Academic collaboration
Mayo Clinic joins forces with theheart.org to provide unique perspective on clinical trials, patient care, news, and events in cardiology

Press center
Latest cardiology-related press releases and communications from industry
Also on theheart.org
Editorial series
4 COMMENTS - Mar 19, 2013 10:00 EDT
View our slideshow for a top-line summary of news-making clinical trials, including PREVAIL, CHAMPION-PHOENIX, STREAM, and HPS2-THRIVE at ACC 2013.
Editorial series
1 COMMENT - Feb 25, 2013 15:10 EST
Join heartwire's Shelley Wood for an indepth discussion with Dr Rita Redberg on the need for better premarket studies for cardiovascular devices and how to balance innovation with safety.
Editorial series
Oct 29, 2012 10:55 EDT
Dr E Magnus Ohman sits down with Drs Melissa Walton-Shirley and Eric Peterson to talk about the gap between research and practice in the US and how to improve the dissemination of information.